miRNEST 2.0: an integrative microRNA resource miRNEST 2.0, an integrative microRNA resource :: Browse



Data derived from PhenomiR


PubMed IDdiseasedisease classtissueexpressionfoldchange maxfoldchange mingenesstudy designmethod
16966691 Pancreatic cancer - 260350 (Pancreatic endocrine tumors - 0) Cancer pancreas miRNA overexpression - 2.94 - Patient study phenotype-control miRNA microarray
16966691 Pancreatic cancer - 260350 (Pancreatic acinar cell carcinoma - 0) Cancer pancreatic acinar cell miRNA overexpression - 3.46 - Patient study phenotype-control miRNA microarray
18230780 Colorectal cancer - 114500 Cancer colorectum miRNA overexpression - 1.2 - Patient study phenotype-control quantitative PCR
18607389 Colorectal cancer - 114500 Cancer colorectum miRNA overexpression - 1.1 - Patient study phenotype-control quantitative PCR
18560586 Ovarian cancer - 604370 (Epithelial ovarian cancer - 0) Cancer ovary miRNA downregulation - 2.5641 - Patient study phenotype-control miRNA microarray
17283129 Neuroblastoma - 256700 Cancer neuroblastoma cell miRNA downregulation - 2.22 - Patient study phenotype-phenotype quantitative PCR
17934639 Leukemia, chronic lymphatic, susceptibility to - 151400 Cancer bone marrow miRNA overexpression - 1.82 - Patient study phenotype-control quantitative PCR
17934639 Cancer - 0 (Leukemia, acute lymphoblastic - 0) Cancer bone marrow miRNA overexpression - 2.32 - Patient study phenotype-control quantitative PCR
17942673 Duchenne muscular dystrophy - 310200 Muscular muscle miRNA overexpression - 3.79 - Patient study phenotype-control miRNA microarray
17942673 Muscular - 0 (muscular dystrophy, facioscapulohumeral - 0) Muscular muscle miRNA overexpression - 3.0 - Patient study phenotype-control miRNA microarray
17942673 Muscular dystrophy, limb-girdle, type 2A - 253600 Muscular muscle miRNA overexpression - 4.1 - Patient study phenotype-control miRNA microarray
17942673 Muscular dystrophy, limb-girdle, type 2B - 253601 Muscular muscle miRNA overexpression - 6.68 - Patient study phenotype-control miRNA microarray
17942673 Miyoshi myopathy - 254130 Muscular muscle miRNA overexpression - 2.64 - Patient study phenotype-control miRNA microarray
17942673 Myopathy, nemaline, 3 - 161800 Muscular muscle miRNA overexpression - 8.34 - Patient study phenotype-control miRNA microarray
17942673 Muscular - 0 (Dermatomyositis - 0) Muscular muscle miRNA overexpression - 3.35 - Patient study phenotype-control miRNA microarray
17622355 Dermatitis, atopic - 603165 Dermatological skin miRNA downregulation - 1.78 - Patient study phenotype-control miRNA microarray
17243163 Muscular - 0 (Uterine leiomyoma - 0) Muscular myoma cell miRNA downregulation - 1.05307 - Patient study phenotype-control miRNA microarray
17243163 Muscular - 0 (Uterine leiomyoma - 0) Muscular myoma cell miRNA overexpression - 1.3294 - Patient study phenotype-control miRNA microarray
17243163 Muscular - 0 (Uterine leiomyoma - 0) Muscular myoma cell miRNA downregulation - 1.07458 - Patient study phenotype-control miRNA microarray
16192569 Breast cancer - 114480 Cancer SK-BR-3 cell miRNA downregulation - 16.6667 - Cell culture study quantitative PCR
18700954 Multiple myeloma - 254500 Cancer plasma cell miRNA overexpression - - - Patient study phenotype-control quantitative PCR
18337557 Leukemia, acute myeloid - 601626 Cancer bone marrow miRNA overexpression - 2.47 - Patient study phenotype-phenotype quantitative PCR
18337557 Leukemia, acute myeloid - 601626 Cancer bone marrow miRNA overexpression - 2.1 - Patient study phenotype-phenotype quantitative PCR
18337557 Leukemia, acute myeloid - 601626 Cancer bone marrow miRNA downregulation - 3.22581 - Patient study phenotype-phenotype quantitative PCR
18337557 Leukemia, acute myeloid - 601626 Cancer bone marrow miRNA overexpression - 2.53 - Patient study phenotype-phenotype quantitative PCR
18728182 Multiple myeloma - 254500 Cancer plasma cell miRNA downregulation - 9.09091 - Patient study phenotype-control miRNA microarray
16754881 Ovarian cancer - 604370 Cancer ovary miRNA overexpression - - - Patient study phenotype-control array CGH
16754881 Melanoma and neural system tumor syndrome - 155755 Cancer cell culture miRNA overexpression - - - Cell culture study array CGH
16192569 Breast cancer - 114480 Cancer MCF-7 cell miRNA downregulation - 25.0 - Cell culture study quantitative PCR
17922033 Rhabdomyosarcoma - 268210 Cancer myoblast miRNA overexpression - 6.68 - Patient study phenotype-control quantitative PCR
16192569 Breast cancer - 114480 Cancer MDA-MB-231 cell miRNA downregulation - 20.0 - Cell culture study quantitative PCR
16192569 Breast cancer - 114480 Cancer MDA-MB-361 cell miRNA downregulation - 10.0 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer PC-3 cell miRNA downregulation - 100.0 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer PPC-1 cell miRNA downregulation - 50.0 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer DU-145 cell miRNA downregulation - 12.5 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer Tsu-Pr1 cell miRNA downregulation - 50.0 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer LNCaP cell miRNA downregulation - 100.0 - Cell culture study quantitative PCR
16192569 Squamous cell carcinoma, head and neck - 601400 Cancer squamous cell carcinoma cell line miRNA downregulation - 20.0 - Cell culture study quantitative PCR
16192569 Squamous cell carcinoma, head and neck - 601400 Cancer squamous cell carcinoma cell line miRNA downregulation - 100.0 - Cell culture study quantitative PCR
18766170 Lung cancer - 211980 Cancer serum miRNA overexpression - - - Patient study phenotype-control deep sequencing
16192569 Pancreatic cancer - 260350 Cancer PANC-1 cell miRNA downregulation - 50.0 - Cell culture study quantitative PCR
16192569 Lung cancer - 211980 Cancer lung cancer cell line miRNA downregulation - 33.3333 - Cell culture study quantitative PCR
16192569 Hematological - 0 Hematological K-562 cell miRNA downregulation - 12.5 - Cell culture study quantitative PCR
18607389 - - embryo miRNA overexpression - 2.49 - Bioprocess study quantitative PCR
17765232 Muscular - 0 (Uterine leiomyoma - 0) Muscular myoma cell miRNA overexpression - 2.48 - Patient study phenotype-control miRNA microarray
17379065 - - cord blood stem cell miRNA overexpression - - - Bioprocess study miRNA microarray
16192569 Lung cancer - 211980 Cancer A-549 cell miRNA downregulation - 50.0 - Cell culture study quantitative PCR
17191223 - - lung miRNA downregulation - - - Bioprocess study quantitative PCR